Literature DB >> 10592119

Diamox((R)) challenge test to decide indications for cerebrospinal fluid shunting in normal pressure hydrocephalus.

H Miyake1, T Ohta, Y Kajimoto, J Deguchi.   

Abstract

OBJECTIVE: The indications for cerebrospinal fluid (CSF) shunting in patients with normal pressure hydrocephalus (NPH) have not been established. Establishment of clear-cut indications for this procedure is essential to ensure cost-effective, and safe treatment. We report the usefulness of the Diamox((R)) challenge test in evaluating indications for CSF shunting in patients with NPH.
METHODS: Pre- and post-operative responses in cerebral blood flow (CBF) and intracranial pressure (ICP) to intravenous administration of Diamox((R)) 1000mg (Diamox((R)) administration) were analysed in 41 patients with NPH who were treated by ventriculoperitoneal (VP) shunt with a programmable valve and an on-off valve.
RESULTS: The preoperative response of ICP to Diamox((R)) administration was more than 10 mmHg in most patients in whom the shunt was effective (shunt effective group), however, it was less than 10 mmHg in most patients in whom the shunt was ineffective (shunt non-effective group). Furthermore, the postoperative response of ICP to Diamox((R)) administration decreased to less than 10 mmHg in most patients in the shunt effective group. The increases in CBF in response to Diamox((R)) administration were similar in the two groups both before and after placement of the VP shunt.
CONCLUSION: Patients in whom ICP increased by more than 10 mmHg in response to Diamox((R)) administration were regarded to have poor CSF circulation and to thus be candidates for CSF shunting. The Diamox((R)) challenge test is a simple, safe procedure, useful in evaluating the response to treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592119     DOI: 10.1007/s007010050417

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Normal pressure hydrocephalus: new concepts on etiology and diagnosis.

Authors:  W G Bradley
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

2.  Increased intracranial volume: a clue to the etiology of idiopathic normal-pressure hydrocephalus?

Authors:  William G Bradley; Francis G Safar; Claudia Furtado; Claudia Hurtado; Justin Ord; John F Alksne
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  Changes in aqueductal CSF stroke volume and progression of symptoms in patients with unshunted idiopathic normal pressure hydrocephalus.

Authors:  A Scollato; R Tenenbaum; G Bahl; M Celerini; B Salani; N Di Lorenzo
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

4.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

Review 5.  Nonsurgical therapy for hydrocephalus: a comprehensive and critical review.

Authors:  Marc R Del Bigio; Domenico L Di Curzio
Journal:  Fluids Barriers CNS       Date:  2016-02-05

6.  Paradigm-shift: radiological changes in the asymptomatic iNPH-patient to be: an observational study.

Authors:  D C Engel; S D Adib; M U Schuhmann; C Brendle
Journal:  Fluids Barriers CNS       Date:  2018-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.